Clinical Trials for Tallac Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Tallac Therapeutics

Clinical Trials (1)

NCT05399654
A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Active, not recruiting
72 participants
Started: Jun 28, 2022 · Completed: May 19, 2026
1 condition1 sponsor12 locations